Diabetes management in Wolcott-Rallison syndrome: analysis from the German/Austrian DPV database
Open Access
- 22 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 15 (1), 1-8
- https://doi.org/10.1186/s13023-020-01359-y
Abstract
Wolcott-Rallison syndrome (WRS) is characterized by permanent early-onset diabetes, skeletal dysplasia and several additional features, e.g. recurrent liver failure. This is the first multicentre approach that focuses on diabetes management in WRS. We searched the German/Austrian Diabetes-Patienten-Verlaufsdokumentation (DPV) registry and studied anthropometric characteristics, diabetes treatment, glycaemic control and occurrence of severe hypoglycaemia (SH) and diabetic ketoacidosis (DKA) in 11 patients with WRS. Furthermore, all local treatment centres were personally contacted to retrieve additional information on genetic characteristics, migration background and rate of consanguinity. Data were analysed at diabetes onset and after a median follow-up period of 3 (1.5–9.0) years (time from diagnosis to latest follow-up). Median age at diabetes onset was 0.2 (0.1–0.3) years, while onset was delayed in one patient (aged 16 months). Seventy percent of patients manifested with DKA. At follow-up, 90% of patients were on insulin pump therapy requiring 0.7 [0.5–1.0] IU of insulin/kg/d. More than two third of patients had HbA1c level ≥ 8%, 40% experienced at least one episode of SH in the course of the disease. Three patients died at 0.6, 5 and 9 years of age, respectively. To the best of our knowledge three patients carried novel mutations in EIF2AK3. Insulin requirements of individuals with WRS registered in DPV appear to be comparable to those of preschool children with well-controlled type 1 diabetes, while glycaemic control tends to be worse and episodes of SH tend to be more common. The majority of individuals with WRS in the DPV registry does not reach glycaemic target for HbA1c as defined for preschool children (< 7.5%). International multicentre studies are required to further improve our knowledge on the care of children with WRS.Keywords
Funding Information
- Bundesministerium für Bildung und Forschung
- Deutsche Diabetes Gesellschaft
- European Foundation for the Study of Diabetes
- Robert Koch Institut
This publication has 35 references indexed in Scilit:
- A Genotype-First Approach for Clinical and Genetic Evaluation of Wolcott-Rallison Syndrome in a Large Cohort of Iranian Children With Neonatal DiabetesCanadian Journal of Diabetes, 2018
- Diabetes Presentation in Infancy: High Risk of Diabetic KetoacidosisDiabetes Care, 2017
- Managing diabetes in preschool childrenPediatric Diabetes, 2017
- Liver, Pancreas and Kidney Transplantation for the Treatment of Wolcott–Rallison SyndromeAmerican Journal of Transplantation, 2014
- Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registriesDiabetologia, 2014
- Re‐alignment‐procedures for Skeletal Dysplasia in Three Patients with Genetically Diverse SyndromesOrthopaedic Surgery, 2013
- Wolcott-Rallison syndrome due to the same mutation (W522X) in EIF2AK3 in two unrelated families and review of the literature*Pediatric Diabetes, 2010
- Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003–2006)European Journal of Clinical Nutrition, 2010
- Wolcott-Rallison SyndromeDiabetes, 2004
- Infancy-onset diabetes mellitus and multiple epiphyseal dysplasiaThe Journal of Pediatrics, 1972